Skip to main content
Robert Bartlett, MD, Emergency Medicine, Lexington, SC

RobertLaingBartlettMD

Emergency Medicine Lexington, SC

Undersea & Hyperbaric Medicine

Chief Medical Officer, Swift Medical

Dr. Bartlett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bartlett's full profile

Already have an account?

  • Office

    149 rudder court
    Lexington, SC 29072
    Phone+1 561-866-5651

Summary

  • Chief Medical Officer, Swift Medical (current) - International company specializing in wound imaging and artificial intelligence for wound prognostics. Special interest in Hyperspectral imaging (400-1,400 nanometers).


    Chief Medical Officer, RestorixHealth 2012-2017 - Operational responsibilities for 250 hospitals, 1,500 providers.


    Chief Medical Officer, National Healing 2002-2010 - Operational responsibilities for 200+ hospital, 1,500 providers.


    CEO and founder of iCertus Health (2017-Charlotte)

    Co-Founder with Microsoft execs of MedaNext (2012-Seattle)
  • LinkedIn Profile

    Executive Summary

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1980 - 1981
  • University of South Alabama College of Medicine
    University of South Alabama College of MedicineClass of 1980

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 1981 - 2025
  • WI State Medical License
    WI State Medical License 2009 - 2021
  • OH State Medical License
    OH State Medical License 2005 - 2019
  • GA State Medical License
    GA State Medical License 1993 - 2001

Publications & Presentations

PubMed

Press Mentions

  • FDA Clears Novalung, the First ECMO System for Long-Term Use
    FDA Clears Novalung, the First ECMO System for Long-Term UseFebruary 25th, 2020
  • FDA Clears Novalung for Treatment of Acute Respiratory and Cardiopulmonary Failure
    FDA Clears Novalung for Treatment of Acute Respiratory and Cardiopulmonary FailureFebruary 24th, 2020